Statistics for Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry
Total visits
| views | |
|---|---|
| Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry | 232 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| 40425_2017_Article_307.pdf | 186 |
Top country views
| views | |
|---|---|
| United States | 168 |
| China | 15 |
| Germany | 10 |
| Ukraine | 5 |
| Russia | 4 |
| Canada | 2 |
| United Kingdom | 2 |
| Greece | 1 |
| Malaysia | 1 |
| Romania | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 47 |
| Fairfield | 27 |
| Houston | 16 |
| Beijing | 11 |
| Kiez | 9 |
| Ann Arbor | 8 |
| Cambridge | 7 |
| Jacksonville | 7 |
| Kiev | 5 |
| Ling | 4 |
| San Francisco | 3 |
| Baltimore | 2 |
| Brooklyn | 2 |
| Seattle | 2 |
| Toronto | 2 |
| Augusta | 1 |
| Bloomington | 1 |
| Gunzenhausen | 1 |
| Hunedoara | 1 |
| Lake Mary | 1 |
| Las Vegas | 1 |
| Liversedge | 1 |
| Malvern | 1 |
| Moscow | 1 |
| Philadelphia | 1 |
| Péfki | 1 |
| Saint Petersburg | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Smolensk | 1 |
| Washington | 1 |
| Zheleznogorsk | 1 |